These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23026050)

  • 1. Cereblon inhibits proteasome activity by binding to the 20S core proteasome subunit beta type 4.
    Lee KM; Lee J; Park CS
    Biochem Biophys Res Commun; 2012 Oct; 427(3):618-22. PubMed ID: 23026050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cereblon is recruited to aggresome and shows cytoprotective effect against ubiquitin-proteasome system dysfunction.
    Sawamura N; Wakabayashi S; Matsumoto K; Yamada H; Asahi T
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1054-1059. PubMed ID: 26188093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mental retardation-linked nonsense mutation in cereblon is rescued by proteasome inhibition.
    Xu G; Jiang X; Jaffrey SR
    J Biol Chem; 2013 Oct; 288(41):29573-85. PubMed ID: 23983124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitination and degradation of c-Jun.
    Yang J; Huang M; Zhou L; He X; Jiang X; Zhang Y; Xu G
    J Biol Chem; 2018 Jun; 293(26):10141-10157. PubMed ID: 29748389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cereblon-mediated degradation of the amyloid precursor protein via the ubiquitin-proteasome pathway.
    Kurihara T; Asahi T; Sawamura N
    Biochem Biophys Res Commun; 2020 Mar; 524(1):236-241. PubMed ID: 31983437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional modulation of AMP-activated protein kinase by cereblon.
    Lee KM; Jo S; Kim H; Lee J; Park CS
    Biochim Biophys Acta; 2011 Mar; 1813(3):448-55. PubMed ID: 21232561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bassoon inhibits proteasome activity via interaction with PSMB4.
    Montenegro-Venegas C; Fienko S; Anni D; Pina-Fernández E; Frischknecht R; Fejtova A
    Cell Mol Life Sci; 2021 Feb; 78(4):1545-1563. PubMed ID: 32651614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and differential expression of a newly identified phosphorylated isoform of the human 20S proteasome beta7 subunit in tumor vs. normal cell lines.
    Eang R; Girbal-Neuhauser E; Xu B; Gairin JE
    Fundam Clin Pharmacol; 2009 Apr; 23(2):215-24. PubMed ID: 19645816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive selection of cereblon modified function including its E3 ubiquitin ligase activity and binding efficiency with AMPK.
    Onodera W; Asahi T; Sawamura N
    Mol Phylogenet Evol; 2019 Jun; 135():78-85. PubMed ID: 30836149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interacting domains in cereblon differentially modulate the immunomodulatory drug-mediated ubiquitination and degradation of its binding partners.
    Tao J; Yang J; Xu G
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):443-449. PubMed ID: 30458989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function.
    Liu Y; Huang X; He X; Zhou Y; Jiang X; Chen-Kiang S; Jaffrey SR; Xu G
    FASEB J; 2015 Dec; 29(12):4829-39. PubMed ID: 26231201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway.
    Hirose Y; Kitazono T; Sezaki M; Abe M; Sakimura K; Funato H; Handa H; Vogt KE; Yanagisawa M
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):23106-23112. PubMed ID: 32848052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cereblon -  a new target of therapy in the treatment of multiple myeloma].
    Staňková M; Bešše L; Sedlaříková L; Vrábel D; Hájek R; Sevčíková S
    Klin Onkol; 2014; 27(5):326-30. PubMed ID: 25312709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of CRBN Gene with Immunomodulatory Drug Resis- tance in Multiple Myeloma].
    Cai QQ; Li J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):892-7. PubMed ID: 26117057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cereblon levels by anti-myeloma agents.
    Díaz-Rodríguez E; Pandiella A
    Leuk Lymphoma; 2016; 57(1):167-76. PubMed ID: 25860244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of cereblon attenuates myocardial ischemia-reperfusion injury.
    Kim J; Lee KM; Park CS; Park WJ
    Biochem Biophys Res Commun; 2014 May; 447(4):649-54. PubMed ID: 24755080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cereblon: promise and challenges for combating human diseases.
    Kim HK; Seol JE; Ahn SW; Jeon S; Park CS; Han J
    Pflugers Arch; 2021 Nov; 473(11):1695-1711. PubMed ID: 34553266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice.
    Lee KM; Yang SJ; Kim YD; Choi YD; Nam JH; Choi CS; Choi HS; Park CS
    Diabetes; 2013 Jun; 62(6):1855-64. PubMed ID: 23349485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 26S proteasome degrades mouse and yeast ornithine decarboxylase in yeast cells.
    Mamroud-Kidron E; Kahana C
    FEBS Lett; 1994 Dec; 356(2-3):162-4. PubMed ID: 7805829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival.
    Xu Q; Hou YX; Langlais P; Erickson P; Zhu J; Shi CX; Luo M; Zhu Y; Xu Y; Mandarino LJ; Stewart K; Chang XB
    BMC Cancer; 2016 May; 16():297. PubMed ID: 27142104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.